Background-Signal transducer and activator of transcription 3 (STAT3) deficiency is responsible for autosomal dominant hyperimmunoglobulin E syndrome, characterized by recurrent bacterial and fungal infections, connective tissue abnormalities, hyperimmunoglobulin E, and Th17 lymphopenia. Although vascular abnormalities have been reported in some patients, the prevalence, characteristics, and etiology of these features have yet to be described. Methods and Results-We prospectively screened 21 adult patients with STAT3 deficiency (median age, 26 years; range, 17 to 44) for vascular abnormalities. We explored the carotid arteries with whole-body magnetic resonance imaging angiography, coronary multislice computed tomography, and echo-tracking-based imaging. We also assayed for serum biomarkers of inflammation and endothelial dysfunction. Finally, we studied murine models of aortic aneurysm in the presence and absence of inhibitors of STAT3-dependent signaling. Ninety-five percent of patients showed brain abnormalities (white matter hyperintensities, lacunar lesions suggestive of ischemic infarcts, and atrophy). We reported peripheral and brain artery abnormalities in 84% of the patients and detected coronary artery abnormalities in 50% of the patients. The most frequent vascular abnormalities were ectasia and aneurysm. The carotid intima-media thickness was markedly decreased, with a substantial increase in circumferential wall stress, indicating the occurrence of hypotrophic arterial remodeling in this STAT3deficient population. Systemic inflammatory biomarker levels correlated poorly with the vascular phenotype. In vivo inhibition of STAT3 signaling or blockade of IL-17A resulted in a marked increase in aneurysm severity and fatal rupture in mouse models. Conclusions-Vascular abnormalities are highly prevalent in patients with STAT3 deficiency. This feature is consistent with the greater susceptibility to vascular aneurysm observed after inhibition of STAT3-dependent signaling in mouse models. (Circ Cardiovasc Genet. 2012;5:25-34.) Key Words: STAT3 Ⅲ autosomal dominant hyper-IgE syndrome Ⅲ primary immunodeficiency Ⅲ vascular abnormalities Ⅲ white matter hyperintensities
S ignal transducer and activator of transcription 3 (STAT3) deficiency is a rare primary immunodeficiency that is referred to as an autosomal dominant hyperimmunoglobulin E syndrome (AD-HIES), caused by mutations in the different domains of STAT3. [1] [2] [3] Its clinical features include dermatitis; staphylococcal cold abscesses of the skin; chronic mucocutaneous candidiasis; recurrent cyst-forming bacterial pneumonia; ear, nose and throat infections; and high immunoglobulin E levels, associated with impaired IL-17 production by T cells and defective Th17 differentiation. 4 -7 Recently, focal brain white matter hyperintensities (WMHs) (in the absence of associated arterial hypertension) 8 and coronary artery abnormalities (ranging from tortuosity to ectatic dilation and focal aneurysms) 9 -13 have been described in patients with AD-HIES.
Clinical Perspective on p 34
Whole-body magnetic resonance angiography (WB-MRA) enables the noninvasive assessment of almost the entire arterial vasculature 14 and can be combined with conventional brain and cardiac magnetic resonance imaging (MRI) to detect brain WMHs and screen for myocardial infarction. In the present study, WB-MRA was further combined with multislice computed tomography (MSCT) of the coronary arteries and ultrasound-based imaging of the carotid arteries to investigate the prevalence and type of vascular abnormalities in adult patients with STAT3 deficiency. To gain further insights into the mechanisms responsible for cardiovascular abnormalities in this setting, we measured circulating levels of cardiovascular risk biomarkers in the patients and examined the impact of alterations in STAT3-related pathways on the development and severity of vascular aneurysms in validated murine models.
Patients, Materials, and Methods

Patients
Twenty-one adult patients (over 16 years of age), registered in the national French primary immunodeficiency database (CEREDIH) as having a heterozygous STAT3 mutation, were enrolled in a French, nationwide, prospective, multicenter study performed between August 2009 and December 2010. The study was approved by the investigational review board at Necker Children's Hospital (Paris, France). All subjects gave their written informed consent. The French National Data Protection Commission authorized the use of a computer database to store personal information (CNIL authorization No. 908256).
The main features of each patient were recorded and scored using the National Institutes of Health scoring system: All the scores were then added together to yield an overall score. Scores over 40 indicate that the subject is likely to carry an AD-HIES phenotype, scores of 20 to 40 points are inconclusive, and scores below 20 points indicate that the subject is unlikely to have an AD-HIES phenotype. 15 For the echo-tracking procedure, healthy control subjects (drawn from a reference database) were matched for gender, age, and mean blood pressure. When 2 or more control subjects were available for a given patient, we chose the person whose arterial parameters were closest to those of the patient.
Imaging
The imaging procedures included brain MRI, gadoliniumenhanced whole-body MRA, and late gadolinium enhancement cardiac MRI in a single session, followed by iodine-enhanced prospective cardiac MSCT, using a weight-based, low-dose, sequential, prospective protocol. See the online-only Data Supplement Appendix. 16 -23 for details of the protocols. Nineteen patients underwent all imaging procedures. MRI was not performed in P18 because of claustrophobia, and MSCT was not performed in P16 because of iodinated contrast agent-related anaphylaxis. Overall vascular lesion scores were calculated by adding up the number of arteries with major lesions. Symmetrical bed lesions were counted as 2 defects, and multiple lesions affecting first-, second-or third-order arteries were counted as a single defect. The overall brain lesion severity was scored by grading the WMHs in both periventricular and subcortical areas and the number of lacunar lesions (see the online-only Data Supplement Appendix).
Carotid Artery Ultrasound and Hemodynamic Measurements
Ultrasound scans were performed to determine the geometric and stiffness parameters of the common carotid arteries in the 21 patients and 21 age-, gender-and arterial blood pressure-matched healthy controls drawn from a reference database. The onlineonly Data Supplement Appendix 24 provides detailed protocols.
Blood Sample Assays
In addition to standard blood analysis, serum from patients with STAT3 deficiency and gender-and age-matched healthy blood donors was assayed for circulating levels of a panel of biomarkers related to inflammation, extracellular matrix remodeling, and endothelial dysfunction. The online-only Data Supplement Appendix details the procedures.
Experimental Models of Aortic Aneurysm and Rupture
We used validated murine models of angiotensin (Ang) II-induced aortic aneurysm and rupture. 25, 26 We treated the mice with either a cell-permeable STAT3 inhibitor that targets the STAT3-SH2 domain and prevents its association with upstream kinases (3 IP injections per week of 25 mg/kg stattic [Calbiochem]) or a mouse monoclonal antimouse IL-17A antibody (2 IP injections per week of 200 g per mouse), as previously described. 27 We also studied mice with severe reductions in STAT3-dependent signaling caused by transgenic overexpression of SOCS3 (Tg-SOCS3). 28, 29 
Statistic Analysis
Values were expressed as a percentage or the meanϮSEM, as appropriate. Statistical tests included the Mann-Whitney U, 2 , and Fisher exact tests. Multiple-group comparisons were performed with a general linear model analysis of variance. Kaplan-Meier survival curves were built and analyzed using a log-rank (Mantel-Cox) test. The threshold for statistical significance was set to PϽ0.05.
Results
Patients
The patients' characteristics are summarized in Table 1 . Twelve men and 9 women with a median age of 26 (range, 17 to 44) and a National Institutes of Health score over 40 (mean, 70.8; range, 52 to 86) were enrolled in the study. No acute, invasive infections were noted at the time of the imaging procedures, but we observed skin manifestations (nϭ4), chronic lower respiratory tract symptoms (nϭ4), 
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and chronic mucocutaneous candidiasis (nϭ4). Cardiovascular risk factors included active smoking (nϭ5), hypertension controlled with dihydropyridine therapy (nϭ1), and overweight (nϭ4). Incidental deep venous thrombosis was reported in 3 patients (P7, P16, and P17) and consisted of leg phlebitis (nϭ3; 6 deep vein thrombosis events) and pulmonary embolism (nϭ2; 3 pulmonary embolism events). None of the study patients had experienced or showed cardiac or neurological vascular events, migraine, or cognitive defects.
Central Nervous System Abnormalities
Brain abnormalities ( Figure 1 , Table 2 , online-only Data Supplement Table I ) were detected on MRI in 19 of the 20 patients (95%), with WMHs in 18 patients, lacunar lesions suggestive of ischemic infarcts in 3 patients, and atrophy in 11 patients (ventricle dilation/subcortical atrophy in 9 and/or cortical atrophy in 6). Brain vascular abnormalities were observed in 7 patients, including 4 with a cerebral artery aneurysm, 4 with arterial dilations and/or tortuosities, and 2 with a vascular agenesia. The WMHs were variously located in the frontal lobes (100% of affected cases), parietal lobes (37.5%), and/or temporal lobes (19%). Seven patients had mild WMH lesions, 7 had moderate lesions, and 4 had severe lesions. In a given patient, the WMH lesions tended to be equally disseminated between the periventricular and subcortical areas ( Figure 1A to 1D ). In 2 patients, asymptomatic aneurysms of the right middle cerebral artery (in P2) and the basilar trunk (in P16) prompted us to recommend intravascular coil embolization ( Figure 1E and 1F) . Unfortunately, P16 died from aneurysm rupture 1 month after diagnosis and before the endovascular procedure could be performed.
Cardiac and Arterial Lesions
Cardiac and coronary artery abnormalities ( Figure 1G to 1L). Only 1 instance of mild stenosis was detected. It is noteworthy that 4 focal areas of late gadolinium enhancement were observed at the apex of the left ventricle in 4 patients by cardiac MRI; this is highly suggestive of small myocardial infarcts ( Figure  1M ). In 3 of these cases, MSCT ( Figure 1L ) detected left main or left anterior descending aneurysms. A 4-step WB-MRA protocol ( Figure 1N ) detected peripheral vascular abnormalities ( Table 2 , online-only Data Supplement Table III ) in 17 of the 20 patients (85%), with artery ectasia in 6 patients (1 per patient), 9 artery aneurysms in 7 patients (including 4 aneurysms located in the brain), 5 artery stenoses Ͼ50% in 4 patients, 9 artery stenoses Ͻ50% in 7 patients, 1 dissection, and 1 arteriovenous fistula ( Figure 1O to 1R) . Minor artery abnormalities were also detected (10 tortuous arteries in 7 patients and 15 artery lumen irregularities in 8 patients). Atherosclerosis in these patients was mild or absent.
Echo-Tracking Findings
No stenoses, plaques, ectasia, or aneurysms were observed in the common carotid arteries; however, the study patients had a markedly thinner intima-media thickness (IMT) and a marginally greater internal carotid diameter, relative to healthy controls (Table 2, Figure 2A ). The extent of the reduction in IMT varied from one patient to another but averaged Ϫ86 m (a 17% reduction, Pϭ0.004). As a consequence, the wall cross-sectional area was 15% lower 
CA indicates coronary artery; CMR, cardiac magnetic resonance imaging; LGE, late gadolinium enhancement; MRI, magnetic resonance imaging; MSCT, multislice computed tomography; P, patient; WB-MRA, whole-body magnetic resonance angiography; Ϫ, absence; ϩ, presence.
Other findings refer to vascular lumen irregularities, tortuosities, dissections, or arteriovenous fistulae. P16 did not undergo MSCT because of iodinated contrast agent-related anaphylaxis, and P18 did not undergo MRI because of claustrophobia.
in patients with STAT3 deficiency than in controls (8.1Ϯ1.6 versus 9.6Ϯ1.7 mm 2 , respectively; Pϭ0.0092), and the wall-to-lumen ratio was 21% lower (Pϭ0.002).
Because arterial blood pressure did not differ significantly when comparing patients and controls, circumferential wall stress was significantly (Pϭ0.001) higher (by 26%) in patients than in control subjects ( Figure 2B ). Patients and controls did not differ significantly in terms of central blood pressure parameters (pulse pressure and augmentation index), carotid stiffness indexes, and aortic pulse wave velocity (Figure 2A) . No significant association between carotid IMT and markers of disease severity (ie, the National Institutes of Health score) was found. Circumferential wall stress level was significantly and positively associated with (1) the number of affected arterial territories identified on imaging (increase for each additional affected artery territory: 2.5 kPa, 95% CI [0.2 to 4.8], Pϭ0.03) and (2) the severity of cerebral lesions (Pϭ0.04) (online-only Data Supplement Figure I) . The total R 2 was 0.42. Circumferential wall stress rose in a stepwise manner with both vascular and cerebral lesion severity ( Figure 2C , Pϭ0.008). In summary, it was found that virtually all patients had vascular abnormalities associated with WMH. These lesions were mostly arterial dilations that often led to ectasia and aneurysms in both the coronary arteries and the periphery. The presence of abnormalities correlated with the observation of higher circumferential wall stress and a thinner IMT, as determined by echo-tracking.
Laboratory Test Data
The patients with STAT3-deficiency had normal standard blood parameters, with the exception of hypereosinophilia (nϭ13), hyper-␣-2 globulinemia (nϭ12), and elevated fibrinogen (nϭ4). Serum lipid, glucose, and uric acid levels were in the normal range. Patients and controls did not significantly differ in terms of circulating levels of inflammatory cytokines. Levels of soluble vascular cell adhesion molecule-1 and of matrix remodeling markers (matrix metalloproteinase-1, tissue inhibitor of metalloproteinase-1 and plasminogen activator inhibitor-1) were higher in patients than in controls, with the exception of lower levels of matrix metalloproteinase-3 (online-only Data Supplement Table IV ). Circulating levels of plasminogen activator inhibitor-1 and IL-1␣ were inversely correlated with carotid IMT in female patients with STAT3 deficiency (rϭϪ0.73, Pϭ0.045). blood pressure ϫ internal diameter/2 ϫ intima-media thickness]) in patients with STAT3 deficiency and healthy controls. C, Values of circumferential wall stress according to the severity of arterial lesions detected in magnetic resonance angiography and multislice computer tomography scans and the severity of central nervous system lesions (white matter hyperintensities and silent brain infarctions). The scoring system was as follows: group 1 patients with STAT3 deficiency are those with moderate brain and vascular abnormalities; group 2 patients with STAT3 deficiency are those with moderate brain abnormalities and severe vascular abnormalities; group 3 patients with STAT3 deficiency are those with severe brain and vascular abnormalities. Median scores were used as cut-off values. It is noteworthy that none of the patients was in the upper category for central nervous system lesions and the lower category for vascular lesions.
STAT3 Signaling and Susceptibility to Vascular Aneurysm in Mouse Models
In vivo inhibition of STAT3 with a small molecule (stattic) that targets the SH2 domain led to a significant (Pϭ0.01) increase in the severity of abdominal aortic aneurysms in a validated Ang II-and TGF-␤-dependent C57Bl/6 mouse model, 26 when compared with treatment with vehicle ( Figure 3A ). This finding suggests that STAT3 signaling has a critical role in the maintenance of vessel integrity. Accordingly, transgenic SOCS3-overexpressing mice that exhibit reduced STAT3 phosphorylation had more severe aneurysms and more fatal vessel ruptures than C57Bl/6 wild-type mice (PϽ0.0001) in the same Ang II-infusion model 26 (online-only Data Supplement Figure II) . Because impaired Th17 differentiation is a hallmark of STAT3 deficiency, 4, 6, 7 we also addressed the role of IL-17A in aneurysm formation. Administration of a neutralizing antimouse IL-17A antibody significantly increased aneurysm severity in response to Ang II infusion, compared with mice treated with control immunoglobulin G (Pϭ0.001). Following IL-17A neutralization, we observed more intense vascular inflammation and greater infiltration of CD3 ϩ T lymphocytes; this observation further supports a vascular protective role for IL-17 signaling ( Figure 3B ).
Discussion
The present report describes the systematic, whole-body screening of patients with STAT3 deficiency for vascular abnormalities. We also sought to identify a mechanistic relationship between this type of abnormality and alterations in STAT3-dependent signaling. Importantly, we found that adult patients with STAT3 deficiency frequently exhibit brain hyperintensities (suggestive of small-vessel alterations) and have an abnormally high prevalence of medium-and large-artery dilations throughout the vascular tree. Analysis of the mechanical properties of the common carotid arteries revealed hypotrophic remodeling of the carotid artery wall, which is consistent with defective mechanotransduction and susceptibility to aneurysm formation.
Brain abnormalities have already been observed in 36 AD-HIES patients for whom STAT3 mutation status data were not reported. 1, 8 The WMHs varied greatly in severity and ranged from isolated, punctuate spots to multifocal, confluent lesions, with a periventricular distribution in many cases, as seen in other WM diseases and notably leukoaraiosis. 30 Leukoaraiosis is observed in elderly subjects and is considered to be a small-vessel disease resulting from a widespread, chronic brain hypoperfusion, with disruption of the blood-brain barrier. The fact that small lacunae were also observed further evokes a primary vascular origin. Thus, the hypothesis of an inflammatory or immune disease of the central nervous system appears to be less probable. Moreover, it is striking to note the absence of vascular risk factors in the present cohort of 
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Vascular Abnormalities in Human STAT3 Deficiency patients with STAT3 deficiency (with the exception of smoking in 25% of the group). 21, 30 We also identified vascular ectasia, aneurysms, irregularities, and stenoses in brain, peripheral, and coronary arteries. Coronary artery abnormalities (notably aneurysms) have been previously reported in patients with AD-HIES, including a recently studied group of 26 STAT3-deficient subjects. 9, 10, 12, 13 Cerebral vascular events (stroke, retinal occlusion, and internal carotid aneurysm) were first reported in 3 patients with AD-HIES, 1 and 5 other cases with lacunar infarction were subsequently identified. 8 In the present cohort (in which all the patients had genetically confirmed STAT3 deficiency), it is noteworthy that all anatomic areas appear to be potentially affected, with a trend toward more damage in small-and medium-diameter vessels. These findings prompt us to conclude that patients with STAT3 deficiency are prone to developing a systemic, vascular disease, regardless of the presence or absence of vascular risk factors and, apparently, infectious complications; however, a potential infectious etiology should always be screened for, since 3 cases of mycotic aneurysm have been reported. 8, 31, 32 The results of common carotid artery hemodynamic measurements revealed an abnormally low IMT and a marked greater circumferential wall stress in patients with STAT3 deficiency; these findings suggest a defect in tensile stress mechanotransduction and a subsequent propensity for arterial dilation and tortuosity in many arterial sites. These data are reminiscent of the inherited Ehlers-Danlos vascular-type syndrome, 23, 33 in which hyperextensibility with scoliosis and other musculoskeletal disorders are major features, a strikingly similar situation to STAT3-deficiency. The vascular abnormalities observed here in patients with STAT3 deficiency may, therefore, result from a systemic connective tissue disorder that includes arterial fragility. The correlation between greater circumferential wall stress and (1) the extent of peripheral arterial lesions and (2) the severity of brain lesions suggests a causal link in the occurrence of vascular lesions such as ectasia and aneurysm. Lastly, this situation contrasts with the greater IMT observed in vascular diseases associated with infections or atheroma. 34 -37 The animal model studies reported here strongly suggest that alterations in STAT3-dependent signaling are directly involved in the vascular phenotype of patients with STAT3 deficiency. Although impaired IL-17 production by T cells is the most important consequence of defective STAT3dependent transcription in patients, the specific role of IL-17 remains to be clearly defined. The murine data evidenced the aggravation of aneurysm formation following neutralization of IL-17A and thus suggest that Th17 deficiency has an important role in mediating the vascular phenotype; however, other IL-17-unrelated STAT3dependent pathways may also be involved. Further studies based on a mouse model with dominant-negative mutations of STAT3 should be able to confirm or negate this hypothesis and help identify the specific cell-type(s) responsible for the vascular phenotype.
The frequency and severity of vascular abnormalities associated with STAT3 deficiency observed here have clinical implications and likely justify the development of screening, surveillance, and therapeutic strategies. Two cohort members were found to require endovascular treatment for a brain aneurysm; unfortunately, 1 died before the procedure. Moreover, STAT3 deficiency appears as an emerging, hereditary cause of brain small-vessel disease whose long-term repercussions remain to be determined. In the literature, WM lesions have been associated with subtle neurological deficits (memory decline, cognitive disability, and depressive symptoms) that may initially go unnoticed by both patients and physicians. 21, 38, 39 Systematic screening for memory and cognitive dysfunctions could thus be offered with a view to define their prognostic significance. Despite the absence of any evidence for effective, preventive strategies, there may be a case for primary prophylaxis of WMH progression, ischemic strokes, vascular leukoencephalopathy, and aneurysm rupture by evicting vascular risk factors and initiating antithrombotic and antihypertensive treatments, if needed. On the basis of the murine data, the use of an Ang II receptor antagonist could legitimately be investigated. This type of preventive measure will have to be carefully evaluated, given the risk of internal hemorrhage associated with the use of antithrombotic agents. 40 In conclusion, adult patients with a STAT3 deficiency were found to have a high prevalence of vascular abnormalities throughout the arterial tree. These abnormalities were characterized by hypotrophic remodeling of the artery wall, increased circumferential stress, and enhanced susceptibility to dilation and aneurysm formation. Some of these aneurysms affect heart and brain vessels and might incur a high vascular risk. Animal model studies strongly suggest a direct role for STAT3-dependent signaling in the vascular phenotype and should facilitate the identification of specific molecular targets for disease modulation.
